Evaluation of an Individualised Written Education Package for Stroke Patients

• Sponsor: Medical Benefits Fund of Australia (Industry)
• Overall Status: Completed
• CT.gov ID: NCT00126295
• Collaborator: (none)
• Enrollment: 130
• Location: 1
• Duration (Months): 23
• Patients Per Site Per Month: 5.7

Study Details

Study Description

Brief Summary

The primary aim of the randomised controlled trial was to evaluate the effectiveness of a tailored written education package ("What you need to know about stroke") on the outcomes of:

• Knowledge about stroke, self-efficacy, anxiety, depression, perceived health status, satisfaction with the content and presentation of the information received, and desire for additional information for patients following stroke and

• Knowledge about stroke, self-efficacy, anxiety, depression, satisfaction with the content and presentation of the information received, and desire for additional information for their carers.

A secondary aim was to evaluate the effect of written information on the outcomes of knowledge about stroke, self-efficacy, anxiety, depression, and perceived health status of patients following stroke and on knowledge about stroke, self-efficacy, anxiety, and depression of their carers.

Condition or Disease	Intervention/Treatment	Phase
Stroke	Device: 'What you need to know about stroke' education package	Phase 2

Study Design

• Study Type: Interventional
• Allocation: Randomized
• Intervention Model: Single Group Assignment
• Masking: Double
• Primary Purpose: Educational/Counseling/Training
• Official Title: Evaluation of a Computer-Generated Individualised Written Education Package for Patients Following Stroke and Their Carers
• Study Start Date: Jun 1, 2003
• Study Completion Date: May 1, 2005

Outcome Measures

Primary Outcome Measures

1. knowledge about stroke []

2. self-efficacy []

3. anxiety []

4. depression []

5. perceived health status (patients only) []

6. satisfaction with the content and presentation of the information received []

7. desire for additional information []

Eligibility Criteria

Criteria

• Ages Eligible for Study: 0 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Had a stroke or transient ischemic attack (TIA) or was the informal carer of a person who had a stroke or TIA;

• Had a reported English-proficiency level, corrected hearing and vision, and communication status adequate to participate in an interview and complete assessment tasks;

• Did not have reported or observable dementia;

• Lived within 50km of the hospital, for ease of follow-up; and

• Was medically stable.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Royal Brisbane Hospital	Brisbane	Queensland	Australia	4029

Sponsors and Collaborators

• Medical Benefits Fund of Australia

Investigators

• Principal Investigator: Tammy C Hoffmann, The University of Queensland
• Principal Investigator: Kryss McKenna, The University of Queensland
• Principal Investigator: Linda Worrall, The University of Queensland
• Principal Investigator: Stephen Read, Royal Brisbane Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• ClinicalTrials.gov Identifier: NCT00126295
• Other Study ID Numbers: 2002000023
• First Posted: Aug 3, 2005
• Last Update Posted: Aug 19, 2005
• Last Verified: Aug 1, 2005

• Additional relevant MeSH terms: Stroke

Study Results

No Results Posted as of Aug 19, 2005